Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
October 12, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Affective Disorders
|
May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review
Hartej Gill, Sabine El-Halabi, Amna Majeed, et al.
JMIR Mental Health
|
October 27, 2022
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative review
David Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
Journal of Affective Disorders
|
January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Journal of Psychiatric Research
|
March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review
Joshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.
Advances in Therapy
|
April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression
Eric P McMullen, Yena Lee, Orly Lipsitz, et al.
Expert Opinion on Drug Safety
|
June 17, 2020
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Expert Review of Neurotherapeutics
|
September 21, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illness
Hartej Gill, Barjot Gill, David Chen-Li, et al.
Journal of Pain and Symptom Management
|
April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced Cancer
Stefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Journal of Psychopharmacology (Oxford, England)
|
October 12, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Affective Disorders
|
May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review
Hartej Gill, Sabine El-Halabi, Amna Majeed, et al.
JMIR Mental Health
|
October 27, 2022
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative review
David Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
Journal of Affective Disorders
|
January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Journal of Psychiatric Research
|
March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review
Joshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.
Advances in Therapy
|
April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression
Eric P McMullen, Yena Lee, Orly Lipsitz, et al.
Expert Opinion on Drug Safety
|
June 17, 2020
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Expert Review of Neurotherapeutics
|
September 21, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illness
Hartej Gill, Barjot Gill, David Chen-Li, et al.
Journal of Pain and Symptom Management
|
April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced Cancer
Stefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
Page
of 6